|
|
|
|
Note: New this year: Live-streamed plenaries
Tune in Sunday, June 12, through Wednesday, June 15, at 10:30 a.m. for the live streaming of our daily plenaries, which bring together the SIR community to honor luminaries, highlight research and hear from experts on topics impacting the specialty.
|
|
|
Posted June 14, 2022
Come celebrate the accomplishments and culture of IR in today’s plenary, held at 10:30 a.m. in the Ballroom. Join Journal of Vascular and Interventional Radiology (JVIR) Editor-in-chief Daniel Y. Sze, MD, PhD, FSIR, as he recognizes award-winning JVIR authors and reviewers, followed by the always-entertaining Film Panel. Read | Live stream the awards
|
|
|
“Have you ever wondered why you never see speeches about paths to leadership for men?” asked Melina R. Kibbe, MD, FACS, FAHA, as she delivered the 2022 SIR Women in Interventional Radiology (WIR) Section InspIRed Lecture at Monday’s WIR Luncheon. The luncheon also featured 2022 WIR Champion Award recipient Kari J. Nelson, MD, FSIR. Read
|
|
|
SIR Foundation brings community together at 2022 Gala
Watch for more pictures and details from the 2022 SIR Foundation Gala in the Summer 2022 IR Quarterly.
|
|
|
|
Attendees were moved by videos of
UFE and other patient stories. |
|
SIR and SIR Foundation leadership joined in the
energetic celebration of IR research. |
|
|
|
Posted June 14, 2022
Interventional radiologists may provide a more effective and minimally invasive treatment for lumbar disc herniations typically treated by open surgery, according to data from a recent European multicenter pilot trial. Read
|
|
|
Physicians may be able to identify several new biomarkers related to immune activation to aid in patient selection for radioembolization of breast cancer liver metastasis, according to data in “Immune activation markers and response to radioembolization of breast cancer liver metastasis: Pilot study.” Read
|
|
|
Posted June 14, 2022
Radioembolization can be considered as first-line treatment for unresectable intrahepatic cholangiocarcinoma (ICH), according to data that will be presented in a Wednesday Abstract of the Year. Read
|
|
|
Posted June 14, 2022
Yttrium-90 (Y-90) microsphere embolization, when deployed as part of second-line therapy, contributed to overall survival in patients with colorectal liver metastases, according to data from the RESiN registry. Read
|
|
|
Researchers successfully created a sheep model that mimics knee osteoarthritis in humans, which will allow IRs to better understand geniculate artery embolization (GAE). Read
|
|
|
Posted June 14, 2022
University of Chicago interventional radiologists collaborated with several specialties to combine treatment to improve the prognosis of patients with intrahepatic cholangiocarcinoma (iCCA). Read
|
|
|
Posted June 14, 2022
Using an AI model that combines patient images and prognostic biomarker information could improve early diagnosis of hepatocellular carcinoma (HCC) among cirrhosis patients. Read
|
|
|
Posted June 14, 2022
Immunotherapy has been an exciting development to treat various cancers. Unfortunately, it is not that effective in patients with hepatocellular carcinoma (HCC) because of the high rates of cirrhosis. But a research team at the MD Anderson Cancer Center has developed a new technique that may improve the effectiveness of immunotherapy in HCC. Read
|
|
|
|
|
|
View the interactive SIR Today preview of the SIR 2022 Annual Scientific Meeting
View the archive of prior years' SIR Today articles |